BIO-key Q3 revenue up 18% to $2.1M; net loss narrows to $0.7M from $1.8M

BIO KEY INTERNATIONAL INC

Revenue $2.1M vs $1.8M; license revenue rose 52% to $1.4M on expanded customer deployments.
Gross margin improved to 78.3% from 18.7%; net loss per share $0.39 vs $3.22 YoY.
Cash position strengthened to $1.8M at Sep 30 from $0.5M at Dec 31, aided by $1.9M warrant inducement.
Recent orders: $910k from financial services customer, $500k from defense ministry; 10,000 users added by British Columbia.
Full-year 2024 revenue expected to meet or exceed $7.75M achieved in 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.